Open Access303 ENHANCED THERAPY SUCCESS OF RENAL CELL CARCINOMA USING TYROSINE KINASE INHIBITORS COMBINED WITH ROTTLERIN
Author(s) -
Matthias Jöckel,
Elke Schneider,
Sabrina Khageh-Hosseini,
Frederik C. Roos,
Christian Hampel,
Joachim W. Thüroff,
Walburgis Brenner
Publication year - 2012
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2012.02.362
Subject(s) - rottlerin , sunitinib , sorafenib , renal cell carcinoma , medicine , cancer research , tyrosine kinase , tyrosine kinase inhibitor , cancer , oncology , kinase , hepatocellular carcinoma , protein kinase c , biology , biochemistry , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom